Welcome to Bristol-Myers Squibb Australia. Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb Australia aims to deliver on its commitments: to our patients and customers, to our employees, to our communities, and to our environment.

Bristol-Myers Squibb
Visit our global website to find out more about Bristol-Myers Squibb worldwide.www.bms.com

News
1 May 2016: Opdivo (nivolumab) listed on the PBS for the treatment of advanced melanoma.
29 March 2016: New BMS guides published about access to medicines in Australia.
18 March 2016: Opdivo (nivolumab) approved for advanced non squamous non-small cell lung cancer
1 March 2016: Daklinza (daclatasvir) listed on the PBS for chronic hepatitis C
31 January 2016: Immuno-oncology agent Opdivo (nivolumab) approved for advanced melanoma & lung cancer
9 June 2015: BMS Australia- Best employer 3rd year running
- Case Study
 
Mission
Our company’s mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Click here to read Bristol-Myers Squibb mission

Publications Find out more about Bristol-Myers Squibb worldwide. Download or view our key corporate publications

Questions about our medicines? Toll free number (Australia only) 1800 067 567 MedInfo.Australia@bms.com